{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:30:21Z","timestamp":1793478621573,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10528-026-11422-1","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:52:10Z","timestamp":1782917530000},"page":"8123-8143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlation Between SGK1 Expression Level and Multiple Myeloma Progression After Autologous Hematopoietic Stem Cell Transplantation"],"prefix":"10.1007","volume":"64","author":[{"given":"Ting","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caili","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianna","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"12","key":"11422_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123151","volume":"15","author":"U Al-Alem","year":"2023","unstructured":"Al-Alem U, Rauscher GH, Alem QA, Kajdacsy-Balla A, Mahmoud AM (2023) Prognostic Value of SGK1 and Bcl-2 in Invasive Breast Cancer. Cancers (Basel) 15(12):3151","journal-title":"Cancers (Basel)"},{"issue":"3","key":"11422_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1152\/physiolgenomics.00025.2005","volume":"21","author":"RD Barber","year":"2005","unstructured":"Barber RD (2005) GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics 21(3):389\u2013395","journal-title":"Physiol Genomics"},{"issue":"1","key":"11422_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/bmt.2015.211","volume":"51","author":"WI Bensinger","year":"2016","unstructured":"Bensinger WI, Becker PS, Gooley TA, Chauncey TR, Maloney DG, Gopal AK, Green DJ, Press OW, Lill M, Ifthikharuddin JJ, Vescio R, Holmberg LA, Phillips GL (2016) A randomized study of melphalan 200 mg\/m2 vs 280 mg\/m2 as a preparative regimen for patients with multiple myeloma undergoing auto-SCT. Bone Marrow Transplant 51(1):67\u201371","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"11422_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.repc.2021.02.023","volume":"41","author":"M Cai","year":"2022","unstructured":"Cai M, Zhang N, Yang D, Jiao Q, Qu P, Zhang Y (2022) High expression of SGK1 in thrombosis of acute ST-segment elevation myocardial infarction: Based on proteomics analysis of intracoronary thrombosis. Rev Port Cardiol 41(4):271\u2013279","journal-title":"Rev Port Cardiol"},{"issue":"1","key":"11422_CR5","first-page":"657","volume":"49","author":"D Chen","year":"2024","unstructured":"Chen D, Li K, Pan L, Chen M, Zhang X, Chen H, Xu J, Cai F (2024) MicroRNA-223-3p Targeting SGK1 Regulates Apoptosis and Inflammation in Sepsis-Associated Acute Kidney Injury. Kidney Blood Press Res 49(1):657\u2013666","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"11422_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84047-2","volume":"15","author":"K Chen","year":"2025","unstructured":"Chen K, Liang H, Yu Z, Guo G, Zheng H, Huang Y, Liu L, Lin J, Long J, Pan R, Chen X, Wang C, Zhang W, Xu Z (2025) Analysis of early efficacy and immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma. Sci Rep 15(1):1222","journal-title":"Sci Rep"},{"key":"11422_CR7","unstructured":"Chinese Medical Association Hematology Branch, Chinese Society of Clinical Oncology Anti Lymphoma Alliance (2020) Zhao Weili Chinese expert consensus on mobilization and collection of autologous hematopoietic stem cells for lymphoma (2020 edition) [J]. Chin J Hematol 41(12):979\u2013983 Chinese"},{"key":"11422_CR8","doi-asserted-by":"crossref","unstructured":"Fagerli UM, Ullrich K, St\u00fchmer T, Holien T, K\u00f6chert K, Holt RU, Bruland O, Chatterjee M, Nogai H, Lenz G, Shaughnessy JD Jr, Mathas S, Sundan A, Bargou RC, D\u00f6rken B, B\u00f8rset M, Janz M (2011) Serum\/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells. Oncogene 30(28):3198\u2013206","DOI":"10.1038\/onc.2011.79"},{"issue":"6","key":"11422_CR9","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1158\/1078-0432.CCR-23-2767","volume":"30","author":"H Fan","year":"2024","unstructured":"Fan H, Wang B, Shi L, Pan N, Yan W, Xu J, Gong L, Li L, Liu Y, Du C, Cui J, Zhu G, Deng S, Sui W, Xu Y, Yi S, Hao M, Zou D, Chen X, Qiu L, An G (2024) Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM). Clin Cancer Res 30(6):1131\u20131142","journal-title":"Clin Cancer Res"},{"key":"11422_CR10","unstructured":"Fu Y, Wei XF, Feng YF, Liu F, Chen QL, Zhao YY, Zhang WJ, Ma T, Huang XJ, Chen Y, Li QF, Zhang QK (2021) The Influence of Serum Homocysteine Level to the Prognosis of Newly Diagnosed Multiple Myeloma Patients and Analysis of Related Factors. Zhongguo Shi Yan Xue Ye Xue Za Zhi 29(2):530\u2013534 Chinese"},{"issue":"3","key":"11422_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41409-018-0264-8","volume":"54","author":"WI Gonsalves","year":"2019","unstructured":"Gonsalves WI, Buadi FK, Ailawadhi S, Bergsagel PL, Chanan Khan AA, Dingli D, Dispenzieri A, Fonseca R, Hayman SR, Kapoor P, Kourelis TV, Lacy MQ, Larsen JT, Muchtar E, Reeder CB, Sher T, Stewart AK, Warsame W, Go RS, Kyle RA, Leung N, Lin Y, Lust JA, Russell SJ, Zeldenrust SR, Fonder AL, Hwa YL, Hobbs MA, Mayo AA, Hogan WJ, Rajkumar SV, Kumar SK, Gertz MA, Roy V (2019) Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement. Bone Marrow Transplant 54(3):353\u2013367","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"11422_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41409-024-02490-1","volume":"60","author":"N Grieb","year":"2025","unstructured":"Grieb N, Oeser A, Ferle M, Hanke F, Flossdorf S, Sauer S, Goldschmidt H, M\u00fcller-Tidow C, Salwender HJ, Fenk R, Engelhardt M, Zeiser R, Vucinic V, Franke GN, Blau IW, Teschner D, Einsele H, Kimmich C, Kull M, Besemer B, Gagelmann N, Kr\u00f6ger N, Neumuth T, Platzbecker U, Merz M (2025) German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST). Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma. Bone Marrow Transpl 60(3):335\u2013345","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"11422_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s12185-022-03353-5","volume":"115","author":"I Hanamura","year":"2022","unstructured":"Hanamura I (2022) Multiple myeloma with high-risk cytogenetics and its treatment approach. Int J Hematol 115(6):762\u2013777","journal-title":"Int J Hematol"},{"issue":"4","key":"11422_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1158\/1541-7786.MCR-15-0422","volume":"14","author":"B Hoang","year":"2016","unstructured":"Hoang B, Shi Y, Frost PJ, Mysore V, Bardeleben C, Lichtenstein A (2016) RETRACTED: SGK Kinase Activity in Multiple Myeloma Cells Protects against ER Stress Apoptosis via a SEK-Dependent Mechanism. Mol Cancer Res 14(4):397\u2013407","journal-title":"Mol Cancer Res"},{"key":"11422_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/10732748221143881","volume":"29","author":"J Li","year":"2022","unstructured":"Li J, Yu H, Wang X, Ye Y, Fang W, Ding N, Mi L, Ping L, Wang X, Song Y, Zhu J (2022) The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma. Cancer Control 29:10732748221143881","journal-title":"Cancer Control"},{"key":"11422_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.822303","volume":"13","author":"RQ Lu","year":"2022","unstructured":"Lu RQ, Zhang YY, Zhao HQ, Guo RQ, Jiang ZX, Guo R (2022) SGK1, a Critical Regulator of Immune Modulation and Fibrosis and a Potential Therapeutic Target in Chronic Graft-Versus-Host Disease. Front Immunol 13:822303","journal-title":"Front Immunol"},{"issue":"1","key":"11422_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-024-00188-w","volume":"5","author":"Q Lu","year":"2024","unstructured":"Lu Q, Yang D, Li H, Niu T, Tong A (2024) Multiple myeloma: signaling pathways and targeted therapy. Mol Biomed 5(1):25","journal-title":"Mol Biomed"},{"issue":"7","key":"11422_CR18","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s41375-023-01936-7","volume":"37","author":"EM Ocio","year":"2023","unstructured":"Ocio EM, Perrot A, Bories P, San-Miguel JF, Blau IW, Karlin L, Martinez-Lopez J, Wang SY, Bringhen S, Marcatti M, Mateos MV, Rodriguez-Otero P, Oliva S, Nogai A, Le Roux N, Dong L, Mac\u00e9 S, Gassiot M, Fitzmaurice T, Oprea C, Moreau P (2023) Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible\/with no immediate intent for autologous stem cell transplantation. Leukemia 37(7):1521\u20131529","journal-title":"Leukemia"},{"issue":"1","key":"11422_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01062-2","volume":"14","author":"O Pasvolsky","year":"2024","unstructured":"Pasvolsky O, Wang Z, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Tang G, Kebriaei P, Aljawai Y, Khan HN, Lee HC, Ye C, Patel KK, Thomas SK, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH (2024) Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation. Blood Cancer J 14(1):82","journal-title":"Blood Cancer J"},{"issue":"8","key":"11422_CR20","doi-asserted-by":"publisher","first-page":"774.e1","DOI":"10.1016\/j.jtct.2024.05.016","volume":"30","author":"AJ Portuguese","year":"2024","unstructured":"Portuguese AJ, Yeh AC, Banerjee R, Holmberg L, Wuliji N, Green DJ, Mielcarek M, Gopal AK, Gooley T, Stevenson P, Cowan AJ (2024) Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive Chemomobilization. Transplant Cell Ther 30(8):774.e1-774.e12","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"11422_CR21","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/ajh.27422","volume":"99","author":"SV Rajkumar","year":"2024","unstructured":"Rajkumar SV (2024) Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol 99(9):1802\u20131824","journal-title":"Am J Hematol"},{"issue":"10","key":"11422_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells13100853","volume":"13","author":"S Rocchi","year":"2024","unstructured":"Rocchi S, Zannetti BA, Marconi G, Lanza F (2024) Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy. Cells 13(10):853","journal-title":"Cells"},{"key":"11422_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-025-03225-4","author":"K Saleem","year":"2025","unstructured":"Saleem K, Xiao Z, Zhu B, Ren Y, Yan Z, Feng J (2025) Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer\u2019s patient-derived cortical neurons. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-025-03225-4","journal-title":"Mol Psychiatry"},{"key":"11422_CR24","doi-asserted-by":"publisher","first-page":"608722","DOI":"10.3389\/fonc.2020.608722","volume":"10","author":"Y Sang","year":"2021","unstructured":"Sang Y, Kong P, Zhang S, Zhang L, Cao Y, Duan X, Sun T, Tao Z, Liu W (2021) SGK1 in Human Cancer: Emerging Roles and Mechanisms. Front Oncol 10:608722","journal-title":"Front Oncol"},{"key":"11422_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/sci\/6738118","volume":"2026","author":"X Shen","year":"2026","unstructured":"Shen X, Liu H, Huang X, Qiu Q, Ru Y, Hui H, Chen J (2026) Prognostic significance of SGK1 expression in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a single-center retrospective study. Stem Cells Int 2026:6738118","journal-title":"Stem Cells Int"},{"issue":"19","key":"11422_CR26","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.3390\/cancers13194867","volume":"13","author":"K Suzuki","year":"2021","unstructured":"Suzuki K, Nishiwaki K, Yano S (2021) Treatment Strategy for Multiple Myeloma to Improve Immunological Environment and Maintain MRD Negativity. Cancers (Basel) 13(19):4867","journal-title":"Cancers (Basel)"},{"issue":"3","key":"11422_CR27","first-page":"1505","volume":"39","author":"Z Tang","year":"2018","unstructured":"Tang Z, Shen Q, Xie H, Zhou Z, Shi G, Zhang C, Mohammed A, Wu Y, Ni S, Zhou X (2018) Serum and glucocorticoid-regulated kinase 1 (SGK1) is a predictor of poor prognosis in non-small cell lung cancer, and its dynamic pattern following treatment with SGK1 inhibitor and \u03b3-ray irradiation was elucidated. Oncol Rep 39(3):1505\u20131515","journal-title":"Oncol Rep"},{"issue":"1","key":"11422_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9010033","volume":"9","author":"M Tsubaki","year":"2021","unstructured":"Tsubaki M, Takeda T, Matsuda T, Seki S, Tomonari Y, Koizumi S, Nagatakiya M, Katsuyama M, Yamamoto Y, Tsurushima K, Ishizaka T, Nishida S (2021) Activation of Serum\/Glucocorticoid Regulated Kinase 1\/Nuclear Factor-\u03baB Pathway Are Correlated with Low Sensitivity to Bortezomib and Ixazomib in Resistant Multiple Myeloma Cells. Biomedicines 9(1):33","journal-title":"Biomedicines"},{"key":"11422_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1479164","volume":"15","author":"X Wan","year":"2025","unstructured":"Wan X, Yu T, Yu T, Cai H (2025) The impact of multiple myeloma drugs treatments on autologous stem cell transplantation in the era of new drugs. Front Oncol 15:1479164","journal-title":"Front Oncol"},{"key":"11422_CR30","doi-asserted-by":"publisher","DOI":"10.1177\/10781552251336172","author":"F Wang","year":"2025","unstructured":"Wang F, Cai Z, Zou D, Chen W, Song Y, Fu C, Hu J, Yang T, Chen X, Yan J, Liu K (2025) Safety, effectiveness and pharmacokinetics of high-dose propylene glycol-free melphalan (EVOMELA) with a prolonged infusion as myeloablative conditioning in Chinese multiple myeloma patients undergoing autologous stem cell transplantation: A prospective phase iv study. J Oncol Pharm Pract. https:\/\/doi.org\/10.1177\/10781552251336172","journal-title":"J Oncol Pharm Pract"},{"issue":"3","key":"11422_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00441-020-03252-3","volume":"382","author":"X Wu","year":"2020","unstructured":"Wu X, Jiang W, Wang X, Zhang C, Cai J, Yu S, Sun J, Tian Z (2020) SGK1 enhances Th9 cell differentiation and airway inflammation through NF-\u03baB signaling pathway in asthma. Cell Tissue Res 382(3):563\u2013574","journal-title":"Cell Tissue Res"},{"issue":"1","key":"11422_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08390-7","volume":"21","author":"R Xu","year":"2021","unstructured":"Xu R, Lin L, Zhang B, Wang J, Zhao F, Liu X, Li Y, Li Y (2021) Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5. BMC Cancer 21(1):687","journal-title":"BMC Cancer"},{"issue":"3","key":"11422_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10549-023-06990-4","volume":"200","author":"J Zhang","year":"2023","unstructured":"Zhang J, Miki Y, Iwabuchi E, Xu J, Kanai A, Sagara Y, Ohi Y, Rai Y, Yamaguchi R, Tanaka M, Ishida T, Suzuki T, Sasano H (2023) Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients. Breast Cancer Res Treat 200(3):323\u2013335","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"11422_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2025.01.027","volume":"83","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Geng C, Song M, Liang H, Zhou K, Liu Y, Wu J, Huang X, Zhou J, Fan J, Peng DH, Zhang L, Cang Y, Sun Y (2025) Loss of SGK1 supports metastatic colonization in hepatocellular carcinoma by promoting resistance to T cell-mediated immunity. J Hepatol 83(2):397\u2013410","journal-title":"J Hepatol"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11422-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-026-11422-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11422-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:02:40Z","timestamp":1793476960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-026-11422-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11422"],"URL":"https:\/\/doi.org\/10.1007\/s10528-026-11422-1","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was approved by the Ethics Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University (No. XJTU1AF-CRF-2023-188).\u00a0Every participant signed the written informed consent.\u00a0All procedures performed in studies involving human participants were in accordance with the standards upheld with those of the 1964 Helsinki Declaration and its later amendments for ethical research involving human subjects.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written Informed consent was obtained from every human participant in the study and the patients participating in the study all agree to publish the research results.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}